Baidu
map
YONSEI MED J 润色咨询

YONSEI MEDICAL JOURNAL

出版年份:1960 年文章数:2192 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:5.0% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1180360, encodeId=279b1180360a1, content=这个杂志接受到online需要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d3f5636668, createdName=ms6000001828451209, createdTime=Tue Jan 04 11:37:59 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517922, encodeId=e04451e922bd, content=12月28号投了一片meta到这个杂志,一直显示为“MS at check-in”,是什么意思啊,什么时候才会开始审稿?要毕业,着急啊。有知道这个杂志的朋友吗,尤其是meta的,谢谢了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da4e1675642, createdName=wabon, createdTime=Wed Dec 30 23:44:00 CST 2015, time=2015-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083009, encodeId=7cbc108300927, content=哪位投过的大神能解答下,MS in review是决定外审了?还是主编在审,不知道是否送审呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Wed Dec 22 10:50:05 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575687, encodeId=b2835e5687a5, content=请问现在您投哪个杂志了<span class="quote">fhy 2018-05-04 09:47:00 发表:<br>想请教各位同行,阴性结果接受概率大不大</span>, beContent=fhy 2018-05-04 09:47:00 发表: 想请教各位同行,阴性结果接受概率大不大, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17c85089244, createdName=145cce1dm39暂无昵称, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573144, encodeId=ee4a5e3144a7, content=请问一下怎么没有看到这个杂志的投稿链接呀,他收综述吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4f862442258, createdName=duaoling, createdTime=Sun Jun 30 00:00:00 CST 2019, time=2019-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570910, encodeId=0aee5e0910cd, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:还可以,一个月审稿,二审半个月回来直接接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70de2488632, createdName=1247372am13(暂无昵称), createdTime=Tue May 14 16:01:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560138, encodeId=8e1a5601388c, content=各位大佬前辈,该杂志接不接受感染方面的临床研究啊?本人新手上路,谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/15/4cbb89e4ef1ceb65b457821b5d99cdcb.jpg, createdBy=a6812419635, createdName=小萌新, createdTime=Wed Aug 15 00:00:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555694, encodeId=9d5b55569431, content=想请教各位同行,阴性结果接受概率大不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=466, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18c088308, createdName=fhy, createdTime=Fri May 04 09:47:00 CST 2018, time=2018-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552679, encodeId=b4655526e99d, content=请问各位大牛,这个杂志这么投稿呀,http://journal.eymj.org/ 网页进不去啊,谢谢了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=487, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9121697595, createdName=吴群英, createdTime=Wed Feb 14 09:20:00 CST 2018, time=2018-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552190, encodeId=79f4552190cd, content=接不接受关于心血管介入的文章? 求助--<span class="quote">leafcyp 2011-06-29 12:30:00 发表:<br></span>, beContent=leafcyp 2011-06-29 12:30:00 发表: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=554, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54532256324, createdName=12175516m95暂无昵称, createdTime=Wed Jan 31 00:00:00 CST 2018, time=2018-01-31, status=1, ipAttribution=)]
    2022-01-04 ms6000001828451209

    这个杂志接受到online需要多久啊

    5

    展开5条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1180360, encodeId=279b1180360a1, content=这个杂志接受到online需要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d3f5636668, createdName=ms6000001828451209, createdTime=Tue Jan 04 11:37:59 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517922, encodeId=e04451e922bd, content=12月28号投了一片meta到这个杂志,一直显示为“MS at check-in”,是什么意思啊,什么时候才会开始审稿?要毕业,着急啊。有知道这个杂志的朋友吗,尤其是meta的,谢谢了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da4e1675642, createdName=wabon, createdTime=Wed Dec 30 23:44:00 CST 2015, time=2015-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083009, encodeId=7cbc108300927, content=哪位投过的大神能解答下,MS in review是决定外审了?还是主编在审,不知道是否送审呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Wed Dec 22 10:50:05 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575687, encodeId=b2835e5687a5, content=请问现在您投哪个杂志了<span class="quote">fhy 2018-05-04 09:47:00 发表:<br>想请教各位同行,阴性结果接受概率大不大</span>, beContent=fhy 2018-05-04 09:47:00 发表: 想请教各位同行,阴性结果接受概率大不大, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17c85089244, createdName=145cce1dm39暂无昵称, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573144, encodeId=ee4a5e3144a7, content=请问一下怎么没有看到这个杂志的投稿链接呀,他收综述吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4f862442258, createdName=duaoling, createdTime=Sun Jun 30 00:00:00 CST 2019, time=2019-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570910, encodeId=0aee5e0910cd, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:还可以,一个月审稿,二审半个月回来直接接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70de2488632, createdName=1247372am13(暂无昵称), createdTime=Tue May 14 16:01:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560138, encodeId=8e1a5601388c, content=各位大佬前辈,该杂志接不接受感染方面的临床研究啊?本人新手上路,谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/15/4cbb89e4ef1ceb65b457821b5d99cdcb.jpg, createdBy=a6812419635, createdName=小萌新, createdTime=Wed Aug 15 00:00:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555694, encodeId=9d5b55569431, content=想请教各位同行,阴性结果接受概率大不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=466, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18c088308, createdName=fhy, createdTime=Fri May 04 09:47:00 CST 2018, time=2018-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552679, encodeId=b4655526e99d, content=请问各位大牛,这个杂志这么投稿呀,http://journal.eymj.org/ 网页进不去啊,谢谢了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=487, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9121697595, createdName=吴群英, createdTime=Wed Feb 14 09:20:00 CST 2018, time=2018-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552190, encodeId=79f4552190cd, content=接不接受关于心血管介入的文章? 求助--<span class="quote">leafcyp 2011-06-29 12:30:00 发表:<br></span>, beContent=leafcyp 2011-06-29 12:30:00 发表: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=554, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54532256324, createdName=12175516m95暂无昵称, createdTime=Wed Jan 31 00:00:00 CST 2018, time=2018-01-31, status=1, ipAttribution=)]
    2015-12-30 wabon

    12月28号投了一片meta到这个杂志,一直显示为“MS at check-in”,是什么意思啊,什么时候才会开始审稿?要毕业,着急啊。有知道这个杂志的朋友吗,尤其是meta的,谢谢了!

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1180360, encodeId=279b1180360a1, content=这个杂志接受到online需要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d3f5636668, createdName=ms6000001828451209, createdTime=Tue Jan 04 11:37:59 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517922, encodeId=e04451e922bd, content=12月28号投了一片meta到这个杂志,一直显示为“MS at check-in”,是什么意思啊,什么时候才会开始审稿?要毕业,着急啊。有知道这个杂志的朋友吗,尤其是meta的,谢谢了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da4e1675642, createdName=wabon, createdTime=Wed Dec 30 23:44:00 CST 2015, time=2015-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083009, encodeId=7cbc108300927, content=哪位投过的大神能解答下,MS in review是决定外审了?还是主编在审,不知道是否送审呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Wed Dec 22 10:50:05 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575687, encodeId=b2835e5687a5, content=请问现在您投哪个杂志了<span class="quote">fhy 2018-05-04 09:47:00 发表:<br>想请教各位同行,阴性结果接受概率大不大</span>, beContent=fhy 2018-05-04 09:47:00 发表: 想请教各位同行,阴性结果接受概率大不大, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17c85089244, createdName=145cce1dm39暂无昵称, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573144, encodeId=ee4a5e3144a7, content=请问一下怎么没有看到这个杂志的投稿链接呀,他收综述吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4f862442258, createdName=duaoling, createdTime=Sun Jun 30 00:00:00 CST 2019, time=2019-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570910, encodeId=0aee5e0910cd, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:还可以,一个月审稿,二审半个月回来直接接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70de2488632, createdName=1247372am13(暂无昵称), createdTime=Tue May 14 16:01:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560138, encodeId=8e1a5601388c, content=各位大佬前辈,该杂志接不接受感染方面的临床研究啊?本人新手上路,谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/15/4cbb89e4ef1ceb65b457821b5d99cdcb.jpg, createdBy=a6812419635, createdName=小萌新, createdTime=Wed Aug 15 00:00:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555694, encodeId=9d5b55569431, content=想请教各位同行,阴性结果接受概率大不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=466, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18c088308, createdName=fhy, createdTime=Fri May 04 09:47:00 CST 2018, time=2018-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552679, encodeId=b4655526e99d, content=请问各位大牛,这个杂志这么投稿呀,http://journal.eymj.org/ 网页进不去啊,谢谢了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=487, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9121697595, createdName=吴群英, createdTime=Wed Feb 14 09:20:00 CST 2018, time=2018-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552190, encodeId=79f4552190cd, content=接不接受关于心血管介入的文章? 求助--<span class="quote">leafcyp 2011-06-29 12:30:00 发表:<br></span>, beContent=leafcyp 2011-06-29 12:30:00 发表: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=554, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54532256324, createdName=12175516m95暂无昵称, createdTime=Wed Jan 31 00:00:00 CST 2018, time=2018-01-31, status=1, ipAttribution=)]
    2021-12-22 916603706

    哪位投过的大神能解答下,MS in review是决定外审了?还是主编在审,不知道是否送审呢?

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1180360, encodeId=279b1180360a1, content=这个杂志接受到online需要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d3f5636668, createdName=ms6000001828451209, createdTime=Tue Jan 04 11:37:59 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517922, encodeId=e04451e922bd, content=12月28号投了一片meta到这个杂志,一直显示为“MS at check-in”,是什么意思啊,什么时候才会开始审稿?要毕业,着急啊。有知道这个杂志的朋友吗,尤其是meta的,谢谢了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da4e1675642, createdName=wabon, createdTime=Wed Dec 30 23:44:00 CST 2015, time=2015-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083009, encodeId=7cbc108300927, content=哪位投过的大神能解答下,MS in review是决定外审了?还是主编在审,不知道是否送审呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Wed Dec 22 10:50:05 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575687, encodeId=b2835e5687a5, content=请问现在您投哪个杂志了<span class="quote">fhy 2018-05-04 09:47:00 发表:<br>想请教各位同行,阴性结果接受概率大不大</span>, beContent=fhy 2018-05-04 09:47:00 发表: 想请教各位同行,阴性结果接受概率大不大, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17c85089244, createdName=145cce1dm39暂无昵称, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573144, encodeId=ee4a5e3144a7, content=请问一下怎么没有看到这个杂志的投稿链接呀,他收综述吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4f862442258, createdName=duaoling, createdTime=Sun Jun 30 00:00:00 CST 2019, time=2019-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570910, encodeId=0aee5e0910cd, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:还可以,一个月审稿,二审半个月回来直接接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70de2488632, createdName=1247372am13(暂无昵称), createdTime=Tue May 14 16:01:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560138, encodeId=8e1a5601388c, content=各位大佬前辈,该杂志接不接受感染方面的临床研究啊?本人新手上路,谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/15/4cbb89e4ef1ceb65b457821b5d99cdcb.jpg, createdBy=a6812419635, createdName=小萌新, createdTime=Wed Aug 15 00:00:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555694, encodeId=9d5b55569431, content=想请教各位同行,阴性结果接受概率大不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=466, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18c088308, createdName=fhy, createdTime=Fri May 04 09:47:00 CST 2018, time=2018-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552679, encodeId=b4655526e99d, content=请问各位大牛,这个杂志这么投稿呀,http://journal.eymj.org/ 网页进不去啊,谢谢了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=487, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9121697595, createdName=吴群英, createdTime=Wed Feb 14 09:20:00 CST 2018, time=2018-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552190, encodeId=79f4552190cd, content=接不接受关于心血管介入的文章? 求助--<span class="quote">leafcyp 2011-06-29 12:30:00 发表:<br></span>, beContent=leafcyp 2011-06-29 12:30:00 发表: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=554, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54532256324, createdName=12175516m95暂无昵称, createdTime=Wed Jan 31 00:00:00 CST 2018, time=2018-01-31, status=1, ipAttribution=)]
    2019-09-01 145cce1dm39暂无昵称

    请问现在您投哪个杂志了fhy 2018-05-04 09:47:00 发表:
    想请教各位同行,阴性结果接受概率大不大

    fhy 2018-05-04 09:47:00 发表: 想请教各位同行,阴性结果接受概率大不大

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1180360, encodeId=279b1180360a1, content=这个杂志接受到online需要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d3f5636668, createdName=ms6000001828451209, createdTime=Tue Jan 04 11:37:59 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517922, encodeId=e04451e922bd, content=12月28号投了一片meta到这个杂志,一直显示为“MS at check-in”,是什么意思啊,什么时候才会开始审稿?要毕业,着急啊。有知道这个杂志的朋友吗,尤其是meta的,谢谢了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da4e1675642, createdName=wabon, createdTime=Wed Dec 30 23:44:00 CST 2015, time=2015-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083009, encodeId=7cbc108300927, content=哪位投过的大神能解答下,MS in review是决定外审了?还是主编在审,不知道是否送审呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Wed Dec 22 10:50:05 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575687, encodeId=b2835e5687a5, content=请问现在您投哪个杂志了<span class="quote">fhy 2018-05-04 09:47:00 发表:<br>想请教各位同行,阴性结果接受概率大不大</span>, beContent=fhy 2018-05-04 09:47:00 发表: 想请教各位同行,阴性结果接受概率大不大, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17c85089244, createdName=145cce1dm39暂无昵称, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573144, encodeId=ee4a5e3144a7, content=请问一下怎么没有看到这个杂志的投稿链接呀,他收综述吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4f862442258, createdName=duaoling, createdTime=Sun Jun 30 00:00:00 CST 2019, time=2019-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570910, encodeId=0aee5e0910cd, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:还可以,一个月审稿,二审半个月回来直接接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70de2488632, createdName=1247372am13(暂无昵称), createdTime=Tue May 14 16:01:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560138, encodeId=8e1a5601388c, content=各位大佬前辈,该杂志接不接受感染方面的临床研究啊?本人新手上路,谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/15/4cbb89e4ef1ceb65b457821b5d99cdcb.jpg, createdBy=a6812419635, createdName=小萌新, createdTime=Wed Aug 15 00:00:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555694, encodeId=9d5b55569431, content=想请教各位同行,阴性结果接受概率大不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=466, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18c088308, createdName=fhy, createdTime=Fri May 04 09:47:00 CST 2018, time=2018-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552679, encodeId=b4655526e99d, content=请问各位大牛,这个杂志这么投稿呀,http://journal.eymj.org/ 网页进不去啊,谢谢了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=487, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9121697595, createdName=吴群英, createdTime=Wed Feb 14 09:20:00 CST 2018, time=2018-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552190, encodeId=79f4552190cd, content=接不接受关于心血管介入的文章? 求助--<span class="quote">leafcyp 2011-06-29 12:30:00 发表:<br></span>, beContent=leafcyp 2011-06-29 12:30:00 发表: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=554, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54532256324, createdName=12175516m95暂无昵称, createdTime=Wed Jan 31 00:00:00 CST 2018, time=2018-01-31, status=1, ipAttribution=)]
    2019-06-30 duaoling

    请问一下怎么没有看到这个杂志的投稿链接呀,他收综述吗?

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1180360, encodeId=279b1180360a1, content=这个杂志接受到online需要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d3f5636668, createdName=ms6000001828451209, createdTime=Tue Jan 04 11:37:59 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517922, encodeId=e04451e922bd, content=12月28号投了一片meta到这个杂志,一直显示为“MS at check-in”,是什么意思啊,什么时候才会开始审稿?要毕业,着急啊。有知道这个杂志的朋友吗,尤其是meta的,谢谢了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da4e1675642, createdName=wabon, createdTime=Wed Dec 30 23:44:00 CST 2015, time=2015-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083009, encodeId=7cbc108300927, content=哪位投过的大神能解答下,MS in review是决定外审了?还是主编在审,不知道是否送审呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Wed Dec 22 10:50:05 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575687, encodeId=b2835e5687a5, content=请问现在您投哪个杂志了<span class="quote">fhy 2018-05-04 09:47:00 发表:<br>想请教各位同行,阴性结果接受概率大不大</span>, beContent=fhy 2018-05-04 09:47:00 发表: 想请教各位同行,阴性结果接受概率大不大, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17c85089244, createdName=145cce1dm39暂无昵称, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573144, encodeId=ee4a5e3144a7, content=请问一下怎么没有看到这个杂志的投稿链接呀,他收综述吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4f862442258, createdName=duaoling, createdTime=Sun Jun 30 00:00:00 CST 2019, time=2019-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570910, encodeId=0aee5e0910cd, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:还可以,一个月审稿,二审半个月回来直接接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70de2488632, createdName=1247372am13(暂无昵称), createdTime=Tue May 14 16:01:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560138, encodeId=8e1a5601388c, content=各位大佬前辈,该杂志接不接受感染方面的临床研究啊?本人新手上路,谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/15/4cbb89e4ef1ceb65b457821b5d99cdcb.jpg, createdBy=a6812419635, createdName=小萌新, createdTime=Wed Aug 15 00:00:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555694, encodeId=9d5b55569431, content=想请教各位同行,阴性结果接受概率大不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=466, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18c088308, createdName=fhy, createdTime=Fri May 04 09:47:00 CST 2018, time=2018-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552679, encodeId=b4655526e99d, content=请问各位大牛,这个杂志这么投稿呀,http://journal.eymj.org/ 网页进不去啊,谢谢了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=487, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9121697595, createdName=吴群英, createdTime=Wed Feb 14 09:20:00 CST 2018, time=2018-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552190, encodeId=79f4552190cd, content=接不接受关于心血管介入的文章? 求助--<span class="quote">leafcyp 2011-06-29 12:30:00 发表:<br></span>, beContent=leafcyp 2011-06-29 12:30:00 发表: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=554, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54532256324, createdName=12175516m95暂无昵称, createdTime=Wed Jan 31 00:00:00 CST 2018, time=2018-01-31, status=1, ipAttribution=)]
    2019-05-14 1247372am13(暂无昵称)

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享:还可以,一个月审稿,二审半个月回来直接接收了

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1180360, encodeId=279b1180360a1, content=这个杂志接受到online需要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d3f5636668, createdName=ms6000001828451209, createdTime=Tue Jan 04 11:37:59 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517922, encodeId=e04451e922bd, content=12月28号投了一片meta到这个杂志,一直显示为“MS at check-in”,是什么意思啊,什么时候才会开始审稿?要毕业,着急啊。有知道这个杂志的朋友吗,尤其是meta的,谢谢了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da4e1675642, createdName=wabon, createdTime=Wed Dec 30 23:44:00 CST 2015, time=2015-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083009, encodeId=7cbc108300927, content=哪位投过的大神能解答下,MS in review是决定外审了?还是主编在审,不知道是否送审呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Wed Dec 22 10:50:05 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575687, encodeId=b2835e5687a5, content=请问现在您投哪个杂志了<span class="quote">fhy 2018-05-04 09:47:00 发表:<br>想请教各位同行,阴性结果接受概率大不大</span>, beContent=fhy 2018-05-04 09:47:00 发表: 想请教各位同行,阴性结果接受概率大不大, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17c85089244, createdName=145cce1dm39暂无昵称, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573144, encodeId=ee4a5e3144a7, content=请问一下怎么没有看到这个杂志的投稿链接呀,他收综述吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4f862442258, createdName=duaoling, createdTime=Sun Jun 30 00:00:00 CST 2019, time=2019-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570910, encodeId=0aee5e0910cd, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:还可以,一个月审稿,二审半个月回来直接接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70de2488632, createdName=1247372am13(暂无昵称), createdTime=Tue May 14 16:01:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560138, encodeId=8e1a5601388c, content=各位大佬前辈,该杂志接不接受感染方面的临床研究啊?本人新手上路,谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/15/4cbb89e4ef1ceb65b457821b5d99cdcb.jpg, createdBy=a6812419635, createdName=小萌新, createdTime=Wed Aug 15 00:00:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555694, encodeId=9d5b55569431, content=想请教各位同行,阴性结果接受概率大不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=466, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18c088308, createdName=fhy, createdTime=Fri May 04 09:47:00 CST 2018, time=2018-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552679, encodeId=b4655526e99d, content=请问各位大牛,这个杂志这么投稿呀,http://journal.eymj.org/ 网页进不去啊,谢谢了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=487, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9121697595, createdName=吴群英, createdTime=Wed Feb 14 09:20:00 CST 2018, time=2018-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552190, encodeId=79f4552190cd, content=接不接受关于心血管介入的文章? 求助--<span class="quote">leafcyp 2011-06-29 12:30:00 发表:<br></span>, beContent=leafcyp 2011-06-29 12:30:00 发表: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=554, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54532256324, createdName=12175516m95暂无昵称, createdTime=Wed Jan 31 00:00:00 CST 2018, time=2018-01-31, status=1, ipAttribution=)]
    2018-08-15 小萌新

    各位大佬前辈,该杂志接不接受感染方面的临床研究啊?本人新手上路,谢谢。

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1180360, encodeId=279b1180360a1, content=这个杂志接受到online需要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d3f5636668, createdName=ms6000001828451209, createdTime=Tue Jan 04 11:37:59 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517922, encodeId=e04451e922bd, content=12月28号投了一片meta到这个杂志,一直显示为“MS at check-in”,是什么意思啊,什么时候才会开始审稿?要毕业,着急啊。有知道这个杂志的朋友吗,尤其是meta的,谢谢了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da4e1675642, createdName=wabon, createdTime=Wed Dec 30 23:44:00 CST 2015, time=2015-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083009, encodeId=7cbc108300927, content=哪位投过的大神能解答下,MS in review是决定外审了?还是主编在审,不知道是否送审呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Wed Dec 22 10:50:05 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575687, encodeId=b2835e5687a5, content=请问现在您投哪个杂志了<span class="quote">fhy 2018-05-04 09:47:00 发表:<br>想请教各位同行,阴性结果接受概率大不大</span>, beContent=fhy 2018-05-04 09:47:00 发表: 想请教各位同行,阴性结果接受概率大不大, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17c85089244, createdName=145cce1dm39暂无昵称, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573144, encodeId=ee4a5e3144a7, content=请问一下怎么没有看到这个杂志的投稿链接呀,他收综述吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4f862442258, createdName=duaoling, createdTime=Sun Jun 30 00:00:00 CST 2019, time=2019-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570910, encodeId=0aee5e0910cd, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:还可以,一个月审稿,二审半个月回来直接接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70de2488632, createdName=1247372am13(暂无昵称), createdTime=Tue May 14 16:01:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560138, encodeId=8e1a5601388c, content=各位大佬前辈,该杂志接不接受感染方面的临床研究啊?本人新手上路,谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/15/4cbb89e4ef1ceb65b457821b5d99cdcb.jpg, createdBy=a6812419635, createdName=小萌新, createdTime=Wed Aug 15 00:00:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555694, encodeId=9d5b55569431, content=想请教各位同行,阴性结果接受概率大不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=466, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18c088308, createdName=fhy, createdTime=Fri May 04 09:47:00 CST 2018, time=2018-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552679, encodeId=b4655526e99d, content=请问各位大牛,这个杂志这么投稿呀,http://journal.eymj.org/ 网页进不去啊,谢谢了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=487, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9121697595, createdName=吴群英, createdTime=Wed Feb 14 09:20:00 CST 2018, time=2018-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552190, encodeId=79f4552190cd, content=接不接受关于心血管介入的文章? 求助--<span class="quote">leafcyp 2011-06-29 12:30:00 发表:<br></span>, beContent=leafcyp 2011-06-29 12:30:00 发表: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=554, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54532256324, createdName=12175516m95暂无昵称, createdTime=Wed Jan 31 00:00:00 CST 2018, time=2018-01-31, status=1, ipAttribution=)]
    2018-05-04 fhy

    想请教各位同行,阴性结果接受概率大不大

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1180360, encodeId=279b1180360a1, content=这个杂志接受到online需要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d3f5636668, createdName=ms6000001828451209, createdTime=Tue Jan 04 11:37:59 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517922, encodeId=e04451e922bd, content=12月28号投了一片meta到这个杂志,一直显示为“MS at check-in”,是什么意思啊,什么时候才会开始审稿?要毕业,着急啊。有知道这个杂志的朋友吗,尤其是meta的,谢谢了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da4e1675642, createdName=wabon, createdTime=Wed Dec 30 23:44:00 CST 2015, time=2015-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083009, encodeId=7cbc108300927, content=哪位投过的大神能解答下,MS in review是决定外审了?还是主编在审,不知道是否送审呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Wed Dec 22 10:50:05 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575687, encodeId=b2835e5687a5, content=请问现在您投哪个杂志了<span class="quote">fhy 2018-05-04 09:47:00 发表:<br>想请教各位同行,阴性结果接受概率大不大</span>, beContent=fhy 2018-05-04 09:47:00 发表: 想请教各位同行,阴性结果接受概率大不大, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17c85089244, createdName=145cce1dm39暂无昵称, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573144, encodeId=ee4a5e3144a7, content=请问一下怎么没有看到这个杂志的投稿链接呀,他收综述吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4f862442258, createdName=duaoling, createdTime=Sun Jun 30 00:00:00 CST 2019, time=2019-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570910, encodeId=0aee5e0910cd, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:还可以,一个月审稿,二审半个月回来直接接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70de2488632, createdName=1247372am13(暂无昵称), createdTime=Tue May 14 16:01:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560138, encodeId=8e1a5601388c, content=各位大佬前辈,该杂志接不接受感染方面的临床研究啊?本人新手上路,谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/15/4cbb89e4ef1ceb65b457821b5d99cdcb.jpg, createdBy=a6812419635, createdName=小萌新, createdTime=Wed Aug 15 00:00:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555694, encodeId=9d5b55569431, content=想请教各位同行,阴性结果接受概率大不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=466, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18c088308, createdName=fhy, createdTime=Fri May 04 09:47:00 CST 2018, time=2018-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552679, encodeId=b4655526e99d, content=请问各位大牛,这个杂志这么投稿呀,http://journal.eymj.org/ 网页进不去啊,谢谢了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=487, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9121697595, createdName=吴群英, createdTime=Wed Feb 14 09:20:00 CST 2018, time=2018-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552190, encodeId=79f4552190cd, content=接不接受关于心血管介入的文章? 求助--<span class="quote">leafcyp 2011-06-29 12:30:00 发表:<br></span>, beContent=leafcyp 2011-06-29 12:30:00 发表: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=554, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54532256324, createdName=12175516m95暂无昵称, createdTime=Wed Jan 31 00:00:00 CST 2018, time=2018-01-31, status=1, ipAttribution=)]
    2018-02-14 吴群英

    请问各位大牛,这个杂志这么投稿呀,http://journal.eymj.org/ 网页进不去啊,谢谢了!

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1180360, encodeId=279b1180360a1, content=这个杂志接受到online需要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d3f5636668, createdName=ms6000001828451209, createdTime=Tue Jan 04 11:37:59 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517922, encodeId=e04451e922bd, content=12月28号投了一片meta到这个杂志,一直显示为“MS at check-in”,是什么意思啊,什么时候才会开始审稿?要毕业,着急啊。有知道这个杂志的朋友吗,尤其是meta的,谢谢了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da4e1675642, createdName=wabon, createdTime=Wed Dec 30 23:44:00 CST 2015, time=2015-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083009, encodeId=7cbc108300927, content=哪位投过的大神能解答下,MS in review是决定外审了?还是主编在审,不知道是否送审呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Wed Dec 22 10:50:05 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575687, encodeId=b2835e5687a5, content=请问现在您投哪个杂志了<span class="quote">fhy 2018-05-04 09:47:00 发表:<br>想请教各位同行,阴性结果接受概率大不大</span>, beContent=fhy 2018-05-04 09:47:00 发表: 想请教各位同行,阴性结果接受概率大不大, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17c85089244, createdName=145cce1dm39暂无昵称, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573144, encodeId=ee4a5e3144a7, content=请问一下怎么没有看到这个杂志的投稿链接呀,他收综述吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4f862442258, createdName=duaoling, createdTime=Sun Jun 30 00:00:00 CST 2019, time=2019-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570910, encodeId=0aee5e0910cd, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:还可以,一个月审稿,二审半个月回来直接接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70de2488632, createdName=1247372am13(暂无昵称), createdTime=Tue May 14 16:01:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560138, encodeId=8e1a5601388c, content=各位大佬前辈,该杂志接不接受感染方面的临床研究啊?本人新手上路,谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/15/4cbb89e4ef1ceb65b457821b5d99cdcb.jpg, createdBy=a6812419635, createdName=小萌新, createdTime=Wed Aug 15 00:00:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555694, encodeId=9d5b55569431, content=想请教各位同行,阴性结果接受概率大不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=466, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18c088308, createdName=fhy, createdTime=Fri May 04 09:47:00 CST 2018, time=2018-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552679, encodeId=b4655526e99d, content=请问各位大牛,这个杂志这么投稿呀,http://journal.eymj.org/ 网页进不去啊,谢谢了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=487, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9121697595, createdName=吴群英, createdTime=Wed Feb 14 09:20:00 CST 2018, time=2018-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552190, encodeId=79f4552190cd, content=接不接受关于心血管介入的文章? 求助--<span class="quote">leafcyp 2011-06-29 12:30:00 发表:<br></span>, beContent=leafcyp 2011-06-29 12:30:00 发表: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=554, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54532256324, createdName=12175516m95暂无昵称, createdTime=Wed Jan 31 00:00:00 CST 2018, time=2018-01-31, status=1, ipAttribution=)]
    2018-01-31 12175516m95暂无昵称

    接不接受关于心血管介入的文章? 求助--leafcyp 2011-06-29 12:30:00 发表:

    leafcyp 2011-06-29 12:30:00 发表:

    0

共36条页码: 1/4页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map